Celgene Corporation drugs

11 results

  • abecma

    (Idecabtagene Vicleucel)
    Celgene Corporation
    Abecma treats adult patients with relapsed or refractory multiple myeloma who have received at least two prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.
    Medication Details
    Drug Interactions

  • idhifa - enasidenib mesylate tablet, film coated

    (Enasidenib Mesylate)
    Celgene Corporation
    IDHIFA treats adults with relapsed or refractory acute myeloid leukemia (AML) who have an IDH2 mutation confirmed by an FDA-approved test.
    Medication Details
    Drug Interactions

  • inrebic - fedratinib hydrochloride capsule

    (Fedratinib Hydrochloride)
    Celgene Corporation
    Inrebic treats adults with intermediate-2 or high-risk primary or secondary myelofibrosis, including post-polycythemia vera and post-essential thrombocythemia myelofibrosis.
    Medication Details
    Drug Interactions

  • onureg - azacitidine tablet, film coated

    (Azacitidine)
    Celgene Corporation
    Onureg is indicated for continued treatment of adults with acute myeloid leukemia who achieved complete remission after intensive induction chemotherapy and cannot complete intensive curative therapy.
    Medication Details
    Drug Interactions

  • pomalyst - pomalidomide capsule

    (Pomalidomide)
    Celgene Corporation
    Pomalyst (with dexamethasone) treats adults with multiple myeloma after at least two prior therapies including lenalidomide and a proteasome inhibitor. Also indicated for AIDS-related Kaposi sarcoma after HAART failure, and for Kaposi sarcoma in HIV-negative adults (accelerated approval).
    Medication Details
    Drug Interactions

  • reblozyl - luspatercept injection, powder, lyophilized, for solution

    (Luspatercept)
    Celgene Corporation
    Reblozyl treats anemia in adults with beta thalassemia requiring regular RBC transfusions, ESA-naïve adults with very low- to intermediate-risk MDS requiring transfusions, and adults with MDS-RS or MDS/MPN-RS-T failing ESA and requiring 2+ RBC units over 8 weeks.
    Medication Details

  • revlimid - lenalidomide capsule

    (Lenalidomide)
    Celgene Corporation
    Revlimid treats adult patients with multiple myeloma (with dexamethasone or as maintenance after stem cell transplant), transfusion-dependent anemia from low-risk myelodysplastic syndromes with deletion 5q, relapsed mantle cell lymphoma, and previously treated follicular or marginal zone lymphoma (with rituximab).
    Medication Details
    Drug Interactions